Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...
Investigational ZORYVE cream 0.05% was formulated for the delicate skin of infants and young children with mild to moderate atopic ...
The condition, which most often affects people in warm, humid climates where fungal spores are common, can trigger nasal ...
Pipeline programs continue to advance, with four clinical data readouts anticipated in 2026; APG777 trial readout timelines accelerated, with Phase 1b in asthma and APEX 52-week Part A data in AD ...
With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...
Topical corticosteroids are recommended as first-line treatment for all levels of atopic dermatitis, as well as for ...
Abrocinitib was slightly more effective than dupilumab in treating atopic dermatitis, both in White patients and in patients with skin of color.
Adults with vs. without atopic disease had higher risks for difficulties after breast reconstruction and bone grafting, according to data presented at the American College of Allergy, Asthma & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback